The resistance mechanisms and treatment strategies for EGFR-mutant advanced non-small-cell lung cancer.
about
Navigating the "No Man's Land" of TKI-Failed EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC): A Review.Liquid Biopsy and Therapeutic Targets: Present and Future Issues in Thoracic Oncology.DNA terminal structure-mediated enzymatic reaction for ultra-sensitive discrimination of single nucleotide variations in circulating cell-free DNA.Calpain 2 knockdown promotes cell apoptosis and restores gefitinib sensitivity through epidermal growth factor receptor/protein kinase B/survivin signaling
P2860
The resistance mechanisms and treatment strategies for EGFR-mutant advanced non-small-cell lung cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
The resistance mechanisms and ...... ed non-small-cell lung cancer.
@en
The resistance mechanisms and ...... ed non-small-cell lung cancer.
@nl
type
label
The resistance mechanisms and ...... ed non-small-cell lung cancer.
@en
The resistance mechanisms and ...... ed non-small-cell lung cancer.
@nl
prefLabel
The resistance mechanisms and ...... ed non-small-cell lung cancer.
@en
The resistance mechanisms and ...... ed non-small-cell lung cancer.
@nl
P2093
P2860
P356
P1433
P1476
The resistance mechanisms and ...... ed non-small-cell lung cancer.
@en
P2093
Wen-Zhao Zhong
Yi-Long Wu
P2860
P304
71358-71370
P356
10.18632/ONCOTARGET.20311
P407
P577
2017-08-17T00:00:00Z